Company Active LTD

Company profile

Consoneai Ltd

Consoneai Ltd is a UK company with status active founded in 2020 based in Yorkshire and the Humber.

CRN
12706787
Founded
2020
Age
6

Overview

Legal name
CONSONEAI LTD
Region
Yorkshire and the Humber
Registered address
OFFICE 5
SANDOWN HOUSE
WETHERBY
ENGLAND
LS22 4DN
Insolvency history
No

Latest accounts

Financial period: 1 May 2024 to 30 Apr 2025

FILLETEDACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
3

Company events

Reference milestones and recent Companies House filing stream events.

5 events
31 Jan
2027

Accounts due

Accounts Due

Next accounts due date

13 Jul
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

29 Jun
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

30 Apr
2025

Accounts filed

Accounts

Last accounts made up date

30 Jun
2020

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2022
Funded years
2022, 2024
Age at first award
2 years

Projects

2024 Collaborative R&D Lead participant

Toxicity predictions of novel drugs in development across different age groups in children healthcare

1 May 2024 to 31 Dec 2024

Awarded
£98,751
Total cost £98,751

ConsoneAI is a biotech business focused on reducing the need for animal testing and developing safer drugs, quicker and more effectively by creating a software platform to predict toxicity adverse effects of new chemicals being considered for clinical development in children's treatment. Our platforms DioScor and DioNexus, predict toxicology values and ph...

2022 Grant for R&D Lead participant

Data mining tool to build database to reduce animal testing in drug development.

1 Nov 2022 to 30 Apr 2023

Awarded
£49,435
Total cost £49,435

ConsoneAI is biotech business focused on reducing the need for animal testing and developing safer drugs quicker and more effectively by creating an Insilco software to predict toxicological values for new chemicals being considered for human therapeutic effect, ie new Drugs. Our Platform is called DioScor and will predict toxicology value and physiologic...

Product types

Collaborative R&D Grant for R&D